Crossmark

In vitro activity of rifampicin, rifapentine and rifabutin in combination with their 25-deacetyl-metabolites against various Mycobacterium tuberculosis lineages

Crossref DOI link: https://doi.org/10.1186/s12941-025-00784-w

Published Online: 2025-02-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Genestet, Charlotte

Bourg, Chloé

Hodille, Elisabeth

Bahuaud, Olivier

Ader, Florence

Goutelle, Sylvain

Dumitrescu, Oana

,
Funding

Funding for this research was provided by:

Agence Nationale de la Recherche (ANR-18-CE17-0020)
License Information

Text and Data Mining valid from 2025-02-28

Version of Record valid from 2025-02-28
More Information

Article History

Received: 25 November 2024

Accepted: 6 February 2025

First Online: 28 February 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below